Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.

PURPOSE To evaluate the contribution of molecular methods for the diagnosis of an acyclovir-resistant HSV-1 bilateral keratitis in an AIDS patient and to report a new point mutation in the nucleotide sequence of the thymidine kinase (tk) gene involved. METHODS A 31 year old HIV-positive female presented with severe, active, bilateral and sight-threatening keratitis of 6 months duration, which was treated unsuccessfully with acyclovir. After corneal biopsy, samples were analysed by standard virological procedures, in situ hybridization, and PCR. The tk gene was cloned and subsequently sequenced. RESULTS Conventional virological methods remained inconclusive. However, in situ hybridization and PCR rapidly confirmed the diagnosis of HSV-1 keratitis. The tk gene sequence revealed the presence of five variations previously described in two reference strains, but also a new point mutation at nucleotide position 431 which leads to an amino-acid change at position 144 that supported the hypothesis of a putatively altered functional form of the enzyme. Intravenous foscarnet treatment in an induction regimen was effective and cicatrization occurred within 3 weeks. CONCLUSIONS PCR and in situ hybridization are effective and powerful techniques when other virological procedures are non-contributive, particularly in immunocompromised patients previously treated with antiviral drugs. The new point mutation identified in the tk gene may be associated with resistance to acyclovir.

[1]  R. Esnouf,et al.  Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. , 2000, The Journal of general virology.

[2]  J. Havlik,et al.  Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  H. Shiota,et al.  Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: Analysis of clinical isolates from herpetic keratitis patients and laboratory strains , 1998, Journal of medical virology.

[4]  D. Kimberlin,et al.  Antiviral resistance: mechanisms, clinical significance, and future implications. , 1996, The Journal of antimicrobial chemotherapy.

[5]  J. Pepose,et al.  Ocular Infection and Immunity , 1996 .

[6]  R. Whitley,et al.  Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. , 1995, The Journal of infectious diseases.

[7]  D. Richman,et al.  Antiviral resistance in clinical practice. , 1995, Antiviral research.

[8]  D M Coen,et al.  Molecular mechanisms of antiviral resistance. , 1995, Antiviral research.

[9]  J. Docherty,et al.  Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine. , 1994, The Journal of general virology.

[10]  A K Field,et al.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs , 1994, Clinical Microbiology Reviews.

[11]  R. Frothingham,et al.  Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. , 1992, Ophthalmology.

[12]  D. Shibata,et al.  Description of an In Situ Hybridization Methodology for Detection of Epstein‐Barr Virus RNA in Paraffin‐Embedded Tissues, with a Survey of Normal and Neoplastic Tissues , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[13]  R. Whitley,et al.  Acyclovir: a decade later. , 1992, The New England journal of medicine.

[14]  M. Aymard,et al.  Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey , 1992, Journal of medical virology.

[15]  J. Cherry,et al.  Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. , 1991, Investigative ophthalmology & visual science.

[16]  J. J. Gray,et al.  Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. , 1990, The British journal of ophthalmology.

[17]  S. Pflugfelder,et al.  Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. , 1990, American journal of ophthalmology.

[18]  J. Sugar,et al.  Herpes Simplex Keratitls in Patients with Acquired Immune Deficlency Syndrome , 1989 .

[19]  T. Darragh,et al.  Rapid detection of cutaneous herpes simplex virus infection with the polymerase chain reaction. , 1989, The Journal of investigative dermatology.

[20]  C. Crumpacker,et al.  Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.

[21]  J. D. Shuler,et al.  External ocular disease and anterior segment disorders associated with AIDS. , 1989, International ophthalmology clinics.

[22]  B. Larder,et al.  Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. , 1986, The Journal of general virology.

[23]  H. Field Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy , 1982, Antimicrobial Agents and Chemotherapy.

[24]  H. Field,et al.  Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance , 1981, Nature.

[25]  S. McKnight The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. , 1980, Nucleic acids research.

[26]  G. Elion,et al.  Inhibition of Herpes Simplex Virus-Induced DNA Polymerase Activity and Viral DNA Replication by 9-(2-Hydroxyethoxymethyl) guanine and Its Triphosphate , 1979, Journal of virology.